[XLS] https://unitedrentals.gcs-web.com/static-files/393...,https://unitedrentals.gcs-web.com/static-files/3932b291-695f-42be-8523-7f6ca1edbed0
[XLS] exhibit c-1,https://ir.macom.com/static-files/886e8fa6-8829-4d44-9c15-89a7aeb4ea7c
[XLS] https://ir.macom.com/static-files/32dceba9-ef83-41...,https://ir.macom.com/static-files/32dceba9-ef83-41cb-bb95-951a8c93c328
[XLS] investors.overstock.com/static-files/a2eaeb07-3862...,http://investors.overstock.com/static-files/a2eaeb07-3862-42ab-b938-2e1ad28ad38e
[XLS] https://investors.xencor.com/static-files/c19ba1a9...,https://investors.xencor.com/static-files/c19ba1a9-1fbc-4f71-ab21-6270410e4b1a
[XLS] https://investor.allakos.com/static-files/f98d4a45...,https://investor.allakos.com/static-files/f98d4a45-287e-444f-ba6e-bdbf562d234f
[XLS] https://investor.agenusbio.com/static-files/09ed68...,https://investor.agenusbio.com/static-files/09ed68e3-4838-4fd7-ba21-d8cb2de9e87e
[XLS] https://investors.paylocity.com/static-files/6228c...,https://investors.paylocity.com/static-files/6228ccd4-5f64-48cd-8d7c-51f2ead749f4
[XLS] https://investors.twistbioscience.com/static-files...,https://investors.twistbioscience.com/static-files/26f95cfe-d29a-48a2-98de-c7e2cb89fb5d
"[XLS] Download XLS - Investor Relations | Revolution Medicines, Inc.",https://ir.revmed.com/static-files/d00f750e-6de8-4123-a10e-2d113651113c
[XLS] https://investors.organogenesis.com/static-files/2...,https://investors.organogenesis.com/static-files/2e45b3ba-3b62-48f2-a816-e3f87da50b49
[XLS] Table_Of_Contents - cloudfront.net,https://d18rn0p25nwr6d.cloudfront.net/CIK-0001423774/472db8c8-7f35-4176-bba5-92cedfcface6.xls
[XLS] https://d18rn0p25nwr6d.cloudfront.net/CIK-00007895...,https://d18rn0p25nwr6d.cloudfront.net/CIK-0000789570/62c42ba6-aa18-4746-911a-6a6949c0da37.xls
"[XLS] current report - Investor Relations | Neoleukin Therapeutics, Inc.",https://investor.neoleukin.com/static-files/8ea942c0-e41e-4351-9442-11628bd4712d
[XLS] https://investor.zynga.com/static-files/d23d4ce7-1...,https://investor.zynga.com/static-files/d23d4ce7-16a3-4529-9e30-db7125264051
[XLS] https://liquidia.com/static-files/9ff3f54b-0a4e-42...,https://liquidia.com/static-files/9ff3f54b-0a4e-4252-b87a-12281a9f2c80
[XLS] https://investors.glpropinc.com/static-files/9c3f4...,https://investors.glpropinc.com/static-files/9c3f4d08-6962-465d-8bab-12dc9b9ea95a
[XLS] price range of our common - Palo Alto - Investors,https://investors.paloaltonetworks.com/static-files/55ee35aa-0ef0-4db0-93b5-4f67436ad688
[XLS] https://ir.arvinas.com/static-files/1b0cae5a-be53-...,https://ir.arvinas.com/static-files/1b0cae5a-be53-412e-a458-de82f162faea
[XLS] https://www.loyaltyventures.com/static-files/8db51...,https://www.loyaltyventures.com/static-files/8db518f0-a22d-4898-9f29-e7c8e1ae214b
[XLS] d exhibits - Investor Relations | Vertex Pharmaceuticals,https://investors.vrtx.com/static-files/e5f3c89f-6738-4998-bbe4-0242b8abeb98
[XLS] https://investor.endo.com/static-files/a6a8174e-0c...,https://investor.endo.com/static-files/a6a8174e-0c79-4291-975b-b1696c5fead7
[XLS] Table - Investor Relations - Natera,https://investor.natera.com/static-files/b1085b33-eb72-4a6d-a5a8-c360d43f204d
[XLS] registration statement - Investors,https://investors.bloominbrands.com/static-files/ccf0b9e0-258b-4b78-b983-331002f14424
[XLS] leased premises,https://ir.carters.com/static-files/23e6c673-ca55-4254-b5f4-362a92b52afa
[XLS] Download XLS - Caesars Investor Relations,https://investor.caesars.com/static-files/c28c91f1-3c2e-4b3a-b01d-49d1ee0fac29
[XLS] Download XLS - Investors - Fluidigm,https://investors.fluidigm.com/static-files/f068eefd-d7e8-4d44-8aaa-6b5011a421f6
[XLS] item 901 financial stateme - Investor Relations,https://ir.civeo.com/static-files/9ab58b50-0f4d-4a7b-a5f8-5254d9a1aac3
[XLS] https://ir.pyxisoncology.com/static-files/171bf29d...,https://ir.pyxisoncology.com/static-files/171bf29d-1377-4499-86c1-6df8a7090d61
[XLS] Table,https://www.bbwinc.com/static-files/9f019d38-5737-4169-8bc2-08056c91eeba
